Intestinal Research

Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis?: You Sun Kim; Intest Res. 2021;19(4):357-359. Published online October 26, 2021; DOI: https://doi.org/10.5217/ir.2021.00120
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Gut microbiome and checkpoint inhibitor colitis: Kanika Sehgal, Sahil Khanna; Intest Res. 2021;19(4):360-364. Published online December 1, 2020; DOI: https://doi.org/10.5217/ir.2020.00116
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

Crohn’s disease at radiological imaging: focus on techniques and intestinal tract: Giuseppe Cicero, Silvio Mazziotti; Intest Res. 2021;19(4):365-378. Published online November 25, 2020; DOI: https://doi.org/10.5217/ir.2020.00097
Cited By 9; Full text PubReader ePub Crossref - TDM PDF

An overview of the gut side of the SARS-CoV-2 infection: Bruna Barbosa da Luz, Natalia Mulinari Turin de Oliveira, Isabella Wzorek França dos Santos, Luana Zampieron Paza, Lara Luisa Valerio de Mello Braga, Fernanda da Silva Platner, Maria Fernanda de Paula Werner, Elizabeth Soares Fernandes, Daniele Maria-Ferreira; Intest Res. 2021;19(4):379-385. Published online November 6, 2020; DOI: https://doi.org/10.5217/ir.2020.00087
Cited By 12; Full text PubReader ePub Crossref - TDM PDF

Inflammatory Bowel Diseases
Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI): Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano; Intest Res. 2021;19(4):386-397. Published online December 1, 2020; DOI: https://doi.org/10.5217/ir.2020.00080
Cited By 14; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease: Rupa Banerjee, Partha Pal, Zaheer Nabi, Upender Shava, Girish Ganesh, D. Nageshwar Reddy; Intest Res. 2021;19(4):398-407. Published online November 20, 2020; DOI: https://doi.org/10.5217/ir.2020.00107
Cited By 10; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study: Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi; Intest Res. 2021;19(4):408-418. Published online November 20, 2020; DOI: https://doi.org/10.5217/ir.2020.00025
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study: Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi; Intest Res. 2021;19(4):419-429. Published online November 10, 2020; DOI: https://doi.org/10.5217/ir.2020.00033
Cited By 12; Full text PubReader ePub Crossref - TDM PDF

Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy: Ryohei Hayashi, Yoshitaka Ueno, Shinji Tanaka, Kana Onishi, Takeshi Takasago, Masaki Wakai, Toshikatsu Naito, Kensuke Sasaki, Shigehiro Doi, Takao Masaki, Kazuaki Chayama; Intest Res. 2021;19(4):430-437. Published online November 9, 2020; DOI: https://doi.org/10.5217/ir.2020.00067
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Graphic abstract

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis: Saransh Jain, Divya Namdeo, Pabitra Sahu, Saurabh Kedia, Peush Sahni, Prasenjit Das, Raju Sharma, Vipin Gupta, Govind Makharia, Lalit Dar, Simon PL Travis, Vineet Ahuja; Intest Res. 2021;19(4):438-447. Published online November 6, 2020; DOI: https://doi.org/10.5217/ir.2020.00055
Cited By 7; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis: Taku Kobayashi, Hiroaki Ito, Toshifumi Ashida, Tadashi Yokoyama, Masakazu Nagahori, Tomoki Inaba, Mitsuhiro Shikamura, Takayoshi Yamaguchi, Tetsuharu Hori, Philippe Pinton, Mamoru Watanabe, Toshifumi Hibi; Intest Res. 2021;19(4):448-460. Published online August 18, 2020; DOI: https://doi.org/10.5217/ir.2020.00026
Cited By 9; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?: Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Evangelia Legaki, Maria Gazouli, Ioannis E. Koutroubakis; Intest Res. 2021;19(4):461-467. Published online August 18, 2020; DOI: https://doi.org/10.5217/ir.2020.00042
Cited By 4; Full text PubReader ePub Crossref - TDM PDF

Hydroxyurea associated ileocecal valve ulcer: evidence for causality: Thevaraajan Jayaraman, Ruveena Bhavani Rajaram, Gin Gin Gan, Ida Hilmi; Intest Res. 2021;19(4):468-471. Published online December 1, 2020; DOI: https://doi.org/10.5217/ir.2020.00099; Full text PubReader ePub Crossref - TDM PDF

Pediatric Crohn’s disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature: Eun Sil Kim, Ji Hyung Park, Yon Ho Choe, Mi Jin Kim; Intest Res. 2021;19(4):472-477. Published online October 29, 2020; DOI: https://doi.org/10.5217/ir.2020.00072
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model: Jihye Park, Da Hye Kim, Soochan Kim, Hyun Woo Ma, I Seul Park, Mijeong Son, Ji Hyung Kim, Yoojin Shin, Seung Won Kim, Jae Hee Cheon; Intest Res. 2021;19(4):478-481. Published online October 26, 2021; DOI: https://doi.org/10.5217/ir.2021.00121
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

An elderly woman with severe enteritis mimicking infectious enteritis: Kazunori Nagashima, Takashi Kato, Taichi Kimura, Kazuma Kishi, Urara Baba; Intest Res. 2021;19(4):482-484. Published online July 3, 2020; DOI: https://doi.org/10.5217/ir.2020.00038; Full text PubReader ePub Crossref - TDM PDF

Previous issues